The S&P 500 snapped a three-session losing streak on Wednesday, staging a modest rebound as a significant drop in Treasury yields, triggered by the U.S. Treasury Department's announcement of an expanded long-dated debt buyback program, offered some relief to equities. However, gains were capped and market direction turned choppy after the release of Federal Reserve meeting minutes revealed that several officials had leaned toward raising interest rates last month.
The benchmark index closed 0.2% higher in New York, while the tech-heavy Nasdaq 100 slipped 0.2%, marking its fourth consecutive daily decline. The Fed's July meeting minutes showed that many policymakers expressed a need to tighten monetary policy if inflation fails to cool, a sentiment that reintroduced an element of caution into the market narrative.
Much of the session's focus remained squarely on the bond market. Just two weeks after announcing its buyback schedule for the current quarter, the Treasury stated it would at least double the size of liquidity support repurchase operations for 10- to 30-year maturities. This move was widely interpreted as a direct response to persistent upward pressure on long-term yields.
"There's no question the government is deeply concerned about the bond market again, so they're giving it another shot in the arm," said Matt Maley, chief market strategist at Miller Tabak + Co. His view was echoed by others who see the Treasury's action as a targeted effort to stabilize the long end of the curve.
"Higher rates at the long end of the yield curve will gradually put pressure on stock valuations, especially as yields start to approach the 5% neighborhood," noted Matt Stucky of Northwestern Mutual Wealth Management. This dynamic kept investors on edge even as they welcomed the short-term relief from falling yields.
The earnings season continued to roll on, with several consumer-focused companies posting results. Target Corp shares advanced after the retailer raised its full-year guidance following a better-than-expected quarterly performance. In the biotech space, Moderna Inc shares surged a staggering 180% after the company announced that a personalized vaccine being developed in partnership with Merck & Co helped reduce the risk of melanoma recurrence. Merck shares also rallied, closing up 13% on the news.
At the closing bell, the S&P 500 was up 0.2% at 7,707.98 points, while the Dow Jones Industrial Average added 0.2% to finish at 53,463.05. The Nasdaq Composite gained 0.2% to 26,331.09, but the Nasdaq 100 bucked the trend with a 0.2% decline to 29,426.02. The small-cap Russell 2000 outperformed, rising 0.5% to 3,032.942.
Comments